Finance
Oracea maker reports Q2 revenues of $6.9 million
Published in Drug Week, September 2nd, 2005
Total revenues for the second quarter of 2005 were $6.9 million compared to $14.4 million in the second quarter of 2004. During the second quarter of 2005, the company recorded a net loss allocable to common stockholders of $5.8 million, or $0.41 per basic and diluted share, compared to a net income allocable to common stockholders of $1.6 million, or $0.11 per basic and diluted share, in the second quarter of 2004. Cash, cash equivalents, and short-term investments totaled approximately $35.7 million at June 30, 2005.
The company's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-09-02)
More Articles from Drug Week
- Breast Cancer
Beta-tubulin isotype alterations linked to docetaxel resistance - Drug Delivery
Data on ways to improve Fuzeon presented at meeting - Drug Development
Two additional sites initiated for phase II trial of ADH-1 - HIV/AIDS Therapy
Positive Thiovir data presented at IAS 2005 conference - Hepatocellular Carcinoma
Phase III study in hepatocellular carcinoma fails to achieve primary endpoint - Acromegaly
Acute octreotide test doesn't predict long-term Sandostatin LAR efficacy - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
